Works matching IS 17424690 AND DT 2012 AND VI 9 AND IP Suppl 2

Results: 438

The evolution of HIV-1 subtypes and disease progression among adults on anti-retroviral drugs in Northern Tanzania.

Published in:

2012

By:

Shao, E.;
Nyombi, B.;
Sabuni, J.

Publication type:

Abstract

CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections.

Published in:

2012

By:

Kwa, S.;
Sadagopal, S.;
Hong, J.;
Gangadhara, S.;
Basu, R.;
Lai, L.;
Iyer, S.;
Araki, K.;
Earl, P.L.;
Wyatt, L.;
Villinger, F.;
Moss, B.;
Ahmed, R.;
Amara, R. R.

Publication type:

Abstract

E-DNA IM or ID delivery prime enhances antibody and T cell responses following recombinant gp120 env boost.

Published in:

2012

By:

Hutnick, N. A.;
Karuppiah, M.;
Pollara, J.;
Yan, J.;
Myles, D. J.;
Broderick, K.;
Morrow, M.;
Sardasai, N.;
Montefiori, D.;
Barnett, S.;
Ferrari, G.;
Weiner, D. B.

Publication type:

Abstract

HIV interactions and the perils of epithelial thinning in the female reproductive tract.

Published in:

2012

By:

Carias, A.;
McRaven, M.;
Anderson, M.;
Henning, T.;
Kersh, E.;
Smith, J.;
Butler, K.;
Vishwanathan, S.;
McNicholl, J. M.;
Hendry, R. M.;
Veazey, R.;
Hope, T.

Publication type:

Abstract

Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER.

Published in:

2012

By:

Han, D.;
Habte, H.;
Qin, Y.;
Takamoto, K.;
LaBranche, C.;
Montefiori, D.;
Cho, M.W.

Publication type:

Abstract

Vector induced skewing of antibody Fc-effector functions.

Published in:

2012

By:

Chung, A.;
Dugast, A.;
Robinson, H.;
Chan, Y.;
Ackerman, M.E.;
Cox, J.;
Koff, W.;
Barouch, D.;
Rerks-Ngarm, S.;
Michael, N.;
Kim, J.;
Alter, G.

Publication type:

Abstract

Natural Killer (NK) cell responses at female genital mucosa to SIV vaginal challenge.

Published in:

2012

By:

Shang, L.;
Duan, J.;
Smith, A.;
Wietgrete, S.;
Zupancic, M.;
Haase, A.

Publication type:

Abstract

Virus-like particles highly expressing DC-SIGN concentrate trimeric HIV-envelope proteins with noncovalently linked immunoreactive gp120 and gp41.

Published in:

2012

By:

Vyas, G. N.

Publication type:

Abstract

Targeting HIV Gag p24 to DICR on dendritic cells induces T cell and potent and long-lasting antibody responses in non-human primates.

Published in:

2012

By:

Flamar, A.;
Le Grand, R.;
Contreras, V.;
Zurawski, S.;
Dereuddre-Bosquet, N.;
Mangeot, I.;
Martinon, F.;
Oh, S.;
Banchereau, J.;
Zurawski, G.;
Levy, Y.

Publication type:

Abstract

2G12/PGT-binding yeast glycoprotein Gp38 elicits mannose-specific HIV-1 Env cross-reactive antibodies.

Published in:

2012

By:

Zhang, H.;
Fu, H.;
Liu, B.;
Luallen, R. J.;
Doms, R. W.;
Smith, D. F.;
Geng, Y.

Publication type:

Abstract

Simple, scalable and robust purification of two HIV-1 subtype C gp120 monomer subunit antigens for phase II clinical trial in Republic of South Africa.

Published in:

2012

By:

Wen, Y.;
Stephenson, S.;
Zambonelli, C.;
Hilt, S.;
Wininger, M.;
Dey, A.;
Barnett, S.;
Carfi, A.

Publication type:

Abstract

Novel AIDS vaccine approach using epithelial stem cells as mucosal antigen-presenting cells.

Published in:

2012

By:

Bonello, G.;
Chenciner, N.;
White, R.;
Salas, M.;
Blancou, P.;
Gauduin, M.

Publication type:

Abstract

Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans.

Published in:

2012

By:

Katinger, D.;
Wagner, A.;
Luque, I.;
Crespillo, S.;
Conejero-Lara, F.;
Roger, M.;
Martin, C.;
Mouz, N.;
Mourao, S.;
Farsang, A.;
Notka, F.;
Malcolm, K.;
Bosquet, N.;
Le Grand, R.;
Moog, C.;
Cope, A.;
Shattock, R.;
Lewis, D.J.;
El Habib, R.

Publication type:

Abstract

Novel vomputational methods for predicting epitopes of potent and broadly neutralizing HIV-1 antibodies.

Published in:

2012

By:

Evans, M. C.;
Paquet, A.;
Phung, P.;
Parikh, A.;
Petropoulos, C.;
Wrin, T.;
Haddad, M.

Publication type:

Abstract

Pre-clinical development of BCG.HIVA(CAT) strain, an antibiotic-free selection strain for HIV-TB pediatric vaccine.

Published in:

2012

By:

Saubi, N.;
Gea-Mallorquí, E.;
Mbewe-Mvula, A.;
Hurtado, C.;
Gatell, J.;
Hanke, T.;
Joseph, J.

Publication type:

Abstract

CN54gp140: product characteristics, peclinical and clinical use - recombinant glycoprotein for HIV immunization.

Published in:

2012

By:

Katinger, D.;
Jeffs, S.;
Altmann, F.;
Cope, A.;
McKay, P.;
Almond, N.;
Sandström, E.;
Hejdeman, B.;
Biberfeld, G.;
Nilsson, C.;
Hallengärd, D.;
Wahren, B.;
Lehner, T.;
Singh, M.;
Lewis, D.J.;
Lacey, C.;
Shattock, R.

Publication type:

Abstract

Design and development of a new lentiviral based anti-HIV therapeutic vaccine.

Published in:

2012

By:

Rodriguez, M.;
Sarry, E.;
Bejanariu, A.;
Casaban, L.;
Abdalla, S.;
Sabbah-Petrover, E.;
Bauche, C.

Publication type:

Abstract

Determination of structural constraint within the HIV proteome through analysis of amino acid microenvironments.

Published in:

2012

By:

Gaiha, G.;
Anahtar, M.;
Rossin, E.;
Walker, B.

Publication type:

Abstract

DNA vaccines that express the MPER of HIV-1 gp41 elicit different antibodies depending upon their transmembrane and cytoplasmic domains.

Published in:

2012

By:

Scott, J. K.;
Gulzar, N.;
Klaric, K.;
Ross, T. M.;
Lu, S.;
Wang, S.

Publication type:

Abstract

Purification of chemically fixed HIV-1 spikes for oriented display on nanoparticles.

Published in:

2012

By:

Zwick, M. B.;
Leaman, D.

Publication type:

Abstract

Structural definition of a novel CD4-induced epitope that is targeted by a single-headed immunoglobulin to effect broad and potent HIV neutralization.

Published in:

2012

By:

Acharya, P.;
Luongo, T. S.;
Matz, J.;
Schmidt, S. D.;
Chuang, G.;
Georgiev, I.;
Kessler, P.;
Yang, Y.;
Chames, P.;
Martin, L.;
Mascola, J. R.;
Kwong, P. D.

Publication type:

Abstract

Native envelope-based immunogens derived from critical timepoints in the development of breadth elicit rapid neutralizing antibodies in rabbits.

Published in:

2012

By:

Malherbe, D. C.;
Hessell, A. J.;
Sather, N. D.;
Guo, B.;
Pandey, S.;
Pissani, F.;
Robins, H.;
Kalams, S.;
Stamatatos, L.;
Haigwood, N. L.

Publication type:

Abstract

Functional properties of an ensemble of candidate germline-encoded precursors of the anti-MPER antibody 4E10.

Published in:

2012

By:

Finton, K.;
Larmen, B.;
Larimore, K.;
Stuart, A.;
Friend, D.;
Vanden Bos, T.;
Greenberg, P.;
Elledge, S.;
Stamatatos, L.;
Strong, R.

Publication type:

Abstract

Rational modification of an HIV-1 gp120 results in enhanced neutralization breadth when used as a DNA prime.

Published in:

2012

By:

Wallace, A.;
Duenas-Decamp, M. J.;
Vaine, M.;
Peters, P. J.;
Wang, S.;
Clapham, P. R.;
Lu, S.

Publication type:

Abstract

Optimizing expression of functional HIV envelopes in rVSV-ΔG vaccine vectors.

Published in:

2012

By:

Wright, K. J.;
Yuan, M.;
Wilson, A.;
Boggiano, C.;
Kemelman, M.;
Tiberio, P.;
Phogat, S.;
Lorenz, I.;
Hoffenberg, S.;
Jurgens, C.;
King, C.;
Caulfield, M.;
Parks, C.

Publication type:

Abstract

Viral vector delivery of Env trimer immunogens.

Published in:

2012

By:

Parks, C. L.;
Rabinovich, S.;
Tiberio, P. J.;
Wright, K. J.;
Yuan, M.;
Delboy, M. G.;
Kemelman, M.;
Wilson, A. J.;
Powell, R. L.;
Hoffenberg, S.;
Chiuchiolo, M. J.;
Boggiano, C.;
Morrow, G.;
Lorenz, I. C.;
Jurgens, C. K.;
Zhang, X.;
Lindsay, R. W.;
Koff, W. C.;
King, C. R.;
Caulfield, M. J.

Publication type:

Abstract

Co-immunization with HIV Env DNA and protein elicit long-lasting strong cellular and humoral immune responses.

Published in:

2012

By:

Li, J.;
Valentin, A.;
Kulkarni, V.;
Alicea, C.;
Kelly Beach, R.;
Rosati, M.;
Jalah, R.;
Reed, S.;
Felber, B. K.;
Pavlakis, G. N.

Publication type:

Abstract

Different biological activity of CD154-SIVgp41 fusion protein vaccine component in naïve or pre-immune individuals.

Published in:

2012

By:

Smith, L. M.;
Parodi, L. M.;
Hodora, V. L.;
Giavedoni, L. D.

Publication type:

Abstract

Skin tattooing as an effective tool for delivering DNA and protein vaccine immunogens.

Published in:

2012

By:

Chiu, Y.;
Jiang, X.;
Kumar, R.;
Hioe, C. E.;
Zolla-Pazner, S.;
Kong, X.

Publication type:

Abstract

Antigenic mimicry of mammalian oligomannose by a naturally occurring bacterial oligosaccharide and its implications for HIV vaccine design.

Published in:

2012

By:

De Castro, C.;
Clark, B. E.;
Auyeung, K.;
Marzaioli, A.;
Stanfield, R. L.;
Wilson, I. A.;
Pantophlet, R.

Publication type:

Abstract

Oral delivery of transgenic plant-derived HIV-1 p24 antigen in low doses shows a superior priming effect in mice compared to higher doses.

Published in:

2012

By:

Lindh, I.;
Bråve, A.;
Hallengärd, D.;
Haddad, R.;
Strid, Å.;
Andersson, S.

Publication type:

Abstract

A new strategy for repeated application of adenovirus based vectors: proof-of-concept in rhesus macaques challenged with SIVmac239.

Published in:

2012

By:

Sun, C.;
Feng, L.;
Xiao, L.;
Li, P.;
Zhang, L.;
Chen, L.

Publication type:

Abstract

Engineered microneedle arrays for transcutaneous HIV vaccine delivery.

Published in:

2012

By:

DeMuth, P.;
Huang, B.;
Min, Y.;
Barouch, D.;
Hammond, P.;
Irvine, D.

Publication type:

Abstract

Comparison of cellular and humoral immune responses induced by primary, consensus or mosaic HIV-1 Env DNA vaccines.

Published in:

2012

By:

Yan, J.;
Pankhong, P.;
Khan, A. S.;
Sardesai, N. Y.;
Weiner, D. B.

Publication type:

Abstract

In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies.

Published in:

2012

By:

Shmelkov, E.;
Krachmarov, C.;
Grigoryan, A.;
Agarwal, A.;
Statnikov, A.;
Cardozo, T.

Publication type:

Abstract

From HIV protein sequences to viral fitness landscapes: a new paradigm for in silico vaccine design.

Published in:

2012

By:

Ferguson, A. L.;
Chakraborty, A. K.

Publication type:

Abstract

Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime.

Published in:

2012

By:

Bauer, A.;
Podola, L.;
Haule, A.;
Sudi, L.;
Nilsson, C.;
Mann, P.;
Missanga, M.;
Kaluwa, B.;
Maboko, L.;
Lueer, C.;
Mwakatima, M.;
Aboud, S.;
Bakari, M.;
Currier, J.;
Robb, M.;
Joseph, S.;
McCormack, S.;
Lyamuya, E.;
Wahren, B.;
Sandström, E.

Publication type:

Abstract

Evaluation of a replication-competent VSV-SIV vaccine candidate.

Published in:

2012

By:

Jurgens, C. K.;
Morrow, G.;
Boggiano, C.;
Panis, M.;
Coleman, J.;
Powell, R.;
Yuan, M.;
Kemelman, M.;
Tamot, N.;
Lopez, M.;
Ouattara, A.;
Iyer, S.;
Backer, M.;
Wright, K.;
Domi, A.;
Chiuchiolo, M.;
King, C.R.;
Caulfield, M.;
Parks, C.

Publication type:

Abstract

Vaccination with dendritic cells loaded with HIV-1 lipopeptides elicits broad T cell immunity and control of viral load in HIV infected patients.

Published in:

2012

By:

Levy, Y.;
Thiébaut, R.;
Montes, M.;
Lacabaratz, C.;
Sloan, L.;
Perusat, S.;
Harrod, C.;
Boucherie, C.;
Zurawski, S.;
Richert, L.;
Chêne, G.;
Banchereau, J.;
Palucka, K.

Publication type:

Abstract

Development of candidate HIV vaccines using VSV vectors to express membrane-anchored MPER immunogen.

Published in:

2012

By:

Yuan, M.;
Wilson, A.;
Kemelman, M.;
Panis, M.;
Lorenz, I.;
Jurgens, C.;
Chiuchiolo, M. J.;
King, R.;
Caulfield, M.;
Parks, C. L.

Publication type:

Abstract

Yeast surface display of HIV Env protein variants for the discovery of novel vaccine immunogens.

Published in:

2012

By:

Grimm, S.;
Ackerman, M.

Publication type:

Abstract

The C-terminal tail of HIV-1 envelope: a unique role for conserved LLP arginines in Env functional properties.

Published in:

2012

By:

Kuhlmann, A.;
Steckbeck, J. D.;
Sturgeon, T. J.;
Craigo, J. K.;
Montelaro, R. C.

Publication type:

Abstract

The emptied bacteriophage T4 head: a novel nanoparticle vehicle to simultaneously deliver HIV-1 antigens and genes into dendritic cells.

Published in:

2012

By:

Rao, V.

Publication type:

Abstract

Antigenicity and immunogenicity of a novel, acute HIV-1 Tanzanian subtype C gp145 envelope protein for clinical development.

Published in:

2012

By:

Polonis, V.;
Wieczorek, L.;
Kalyanaraman, V.;
Matyas, G.;
Whitney, S.;
Williams, C.;
Tovanabutra, S.;
Sanders-Buell, E.;
Wesberry, M.;
Ochsenbauer, C.;
Chenine, A.;
Rao, M.;
Tong, T.;
Alving, C.;
Cheng, H.;
Zolla-Pazner, S.;
Michael, N.;
VanCott, T.;
Marovich, M.

Publication type:

Abstract

Immunogenic selection of HIV-1 MPER epitopes for improved vaccine design.

Published in:

2012

By:

Wieczorek, L.;
Rao, M.;
Peachman, K.;
Steers, N.;
Marovich, M.;
Michael, N.;
Polonis, V.;
Rao, V.

Publication type:

Abstract

Novel strategies for HIV-1 epitope delivery using foamy viral hybrid proteins and vectors.

Published in:

2012

By:

Mühle, M.;
Bleiholder, A.;
Hoffmann, K.;
Löchelt, M.;
Denner, J.

Publication type:

Abstract

Molecular epidemiology of the protective RV144 V2 loop epitope.

Published in:

2012

By:

Cardozo, T.

Publication type:

Abstract

Development of an imaging based virus aggregation assay for vaccine development.

Published in:

2012

By:

Stieh, D.;
Gioia, C.;
McRaven, M.;
Cianci, G.;
Kiser, P.;
Hope, T.

Publication type:

Abstract

Transforming epitope-specific gp120 monomerbased probes into immunogens with N-linked glycan masking.

Published in:

2012

By:

Chuang, G.;
Boyington, J. C.;
Nabel, G. J.;
Kwong, P. D.;
Georgiev, I.

Publication type:

Abstract

A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 determinant for neutralization but not for antigen recognition.

Published in:

2012

By:

Weissenhorn, W.;
Lutje Hulsik, D.;
Hock, M.;
Liu, Y. Y.;
Strokappe, N. M.;
Khattabi, M. E.;
Langedijk, J. P.;
McCoy, L. E.;
Forsman-Quigley, A.;
Aasa-Chapman, M. M.;
Weiss, R. A.;
Verrips, T. C.;
Rutten, L.

Publication type:

Abstract